MENU
Home
Add Document
Sign In
Create An Account
PDF Reader
Full Text
Downloaded by: Kings's College London 137.73.144.138 - 4/18/2017 5:20:59 AM
Downloaded by: Kings's College London 137.73.144.138 - 4/18/2017 5:20:59 AM
Downloaded by: Kings's College London 137.73.144.138 - 4/18/2017 5:20:59 AM
Downloaded by: Kings's College London 137.73.144.138 - 4/18/2017 5:20:59 AM
Downloaded by: Kings's College London 137.73.144.138 - 4/18/2017 5:20:59 AM
Suggest Documents
Pharmacokinetics of aztreonam in patients with liver cirrhosis and ascites.
Pharmacokinetics of famotidine in patients with cirrhosis and ascites.
Fleroxacin pharmacokinetics in patients with liver cirrhosis.
Ascites in patients with cirrhosis.
The pharmacokinetics of perindopril in patients with liver cirrhosis.
Pharmacokinetics of metoclopramide in patients with liver cirrhosis.
The pharmacokinetics of enalapril in patients with compensated liver cirrhosis.
Prevalence of spontaneous bacterial peritonitis in liver cirrhosis with ascites.
Carvedilol use is associated with improved survival in patients with liver cirrhosis and ascites.
Pharmacokinetics of paroxetine in patients with cirrhosis.
Pharmacokinetics of lomefloxacin in patients with cirrhosis.
Pharmacokinetics of ketanserin in patients with cirrhosis.
Pharmacokinetics of encainide in patients with cirrhosis.
The pharmacokinetics of cefodizime in children.
Chronic pancreatitis associated with chylous ascites simulating liver cirrhosis.
Pharmacokinetics of cefodizime in normal individuals and in patients with renal failure.
Ascites, refractory ascites and hyponatremia in cirrhosis.
Pharmacokinetics of molsidomine and its active metabolite, linsidomine, in patients with liver cirrhosis.
Ascites increases the resting energy expenditure in liver cirrhosis.
Clinical efficacy of tolvaptan for treatment of refractory ascites in liver cirrhosis patients.
Impact of rifaximin on the frequency and characteristics of spontaneous bacterial peritonitis in patients with liver cirrhosis and ascites.
Outcome of sublay mesh repair in non-complicated umbilical hernia with liver cirrhosis and ascites.
An evaluation of the safety of pure laparoscopic hepatectomy in patients with liver cirrhosis: investigations including serum albumin and ascites.
Whole-body and segmental bioelectrical-impedance analysis in patients with cirrhosis of the liver: changes after treatment of ascites.
Pharmacokinetics of cefodizime in patients with liver cirrhosis and ascites.
The pharmacokinetics of cefodizime were studied in 6 healthy male volunteers (group A) and 6 patients with liver cirrhosis and ascites (group B) recei...
2MB Sizes
0 Downloads
0 Views
Download PDF
Recommend Documents
Pharmacokinetics of aztreonam in patients with liver cirrhosis and ascites.
Pharmacokinetics of famotidine in patients with cirrhosis and ascites.
Fleroxacin pharmacokinetics in patients with liver cirrhosis.
Ascites in patients with cirrhosis.
The pharmacokinetics of perindopril in patients with liver cirrhosis.
Pharmacokinetics of metoclopramide in patients with liver cirrhosis.
The pharmacokinetics of enalapril in patients with compensated liver cirrhosis.
Prevalence of spontaneous bacterial peritonitis in liver cirrhosis with ascites.
Carvedilol use is associated with improved survival in patients with liver cirrhosis and ascites.
Pharmacokinetics of paroxetine in patients with cirrhosis.
×
Sign In
Login with Facebook
Don't have an account?
Forgot Password?
×
Sign Up
By clicking register, I agree to your terms